Literature DB >> 16510635

Popular ergogenic drugs and supplements in young athletes.

Ryan Calfee1, Paul Fadale.   

Abstract

Ergogenic drugs are substances that are used to enhance athletic performance. These drugs include illicit substances as well as compounds that are marketed as nutritional supplements. Many such drugs have been used widely by professional and elite athletes for several decades. However, in recent years, research indicates that younger athletes are increasingly experimenting with these drugs to improve both appearance and athletic abilities. Ergogenic drugs that are commonly used by youths today include anabolic-androgenic steroids, steroid precursors (androstenedione and dehydroepiandrosterone), growth hormone, creatine, and ephedra alkaloids. Reviewing the literature to date, it is clear that children are exposed to these substances at younger ages than in years past, with use starting as early as middle school. Anabolic steroids and creatine do offer potential gains in body mass and strength but risk adverse effects to multiple organ systems. Steroid precursors, growth hormone, and ephedra alkaloids have not been proven to enhance any athletic measures, whereas they do impart many risks to their users. To combat this drug abuse, there have been recent changes in the legal status of several substances, changes in the rules of youth athletics including drug testing of high school students, and educational initiatives designed for the young athlete. This article summarizes the current literature regarding these ergogenic substances and details their use, effects, risks, and legal standing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510635     DOI: 10.1542/peds.2005-1429

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

Review 1.  Performance-enhancing drugs.

Authors:  Christopher Dandoy; Rani S Gereige
Journal:  Pediatr Rev       Date:  2012-06

2.  Interdental spacing and orthodontic treatment in competitive athletes: clues to doping with growth hormones?

Authors:  Jens Christoph Türp; Heinz Lünsch; Ralf Johannes Radlanski
Journal:  J Orofac Orthop       Date:  2010-10-21       Impact factor: 1.938

Review 3.  The continuing story of nutritional supplements and doping infractions.

Authors:  Olivier de Hon; Bart Coumans
Journal:  Br J Sports Med       Date:  2007-11       Impact factor: 13.800

4.  Anabolic androgenic steroids induce micronuclei in buccal mucosa cells of bodybuilders.

Authors:  O Torres-Bugarín; R Covarrubias-Bugarín; A L Zamora-Perez; B M G Torres-Mendoza; M García-Ulloa; F G Martínez-Sandoval
Journal:  Br J Sports Med       Date:  2007-05-14       Impact factor: 13.800

5.  Philosophy on steroids: why the anti-doping position could use a little enhancement.

Authors:  Brent M Kious
Journal:  Theor Med Bioeth       Date:  2008-10-22

Review 6.  Performance-Enhancing Drug Use in Adolescence.

Authors:  Nicole D White; James Noeun
Journal:  Am J Lifestyle Med       Date:  2016-11-29

Review 7.  Muscle Dysmorphia Symptomatology and Associated Psychological Features in Bodybuilders and Non-Bodybuilder Resistance Trainers: A Systematic Review and Meta-Analysis.

Authors:  Lachlan Mitchell; Stuart B Murray; Stephen Cobley; Daniel Hackett; Janelle Gifford; Louise Capling; Helen O'Connor
Journal:  Sports Med       Date:  2017-02       Impact factor: 11.136

8.  Alcohol, tobacco, illicit drugs, and performance enhancers: a comparison of use by college student athletes and nonathletes.

Authors:  David A Yusko; Jennifer F Buckman; Helene R White; Robert J Pandina
Journal:  J Am Coll Health       Date:  2008 Nov-Dec

9.  Acute citrulline malate supplementation improves upper- and lower-body submaximal weightlifting exercise performance in resistance-trained females.

Authors:  Jordan M Glenn; Michelle Gray; Lauren N Wethington; Matthew S Stone; Rodger W Stewart; Nicole E Moyen
Journal:  Eur J Nutr       Date:  2015-12-11       Impact factor: 5.614

Review 10.  Beyond muscles: The untapped potential of creatine.

Authors:  Lisa A Riesberg; Stephanie A Weed; Thomas L McDonald; Joan M Eckerson; Kristen M Drescher
Journal:  Int Immunopharmacol       Date:  2016-01-08       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.